Sofinnova Investments

Sofinnova is a healthcare investment firm focused on life sciences and therapeutics that aim to improve patient lives. It partners with entrepreneurs to navigate drug development, regulatory processes, and company building across the U.S. and Europe. The firm invests across seed to early-stage rounds and corporate spinouts, leveraging deep scientific and industry expertise. It has funded 115 companies, led 53 IPOs, and achieved 31 FDA drug approvals, reflecting a strong track record in funding transformative therapies. The firm manages approximately $3.3B in assets under management and seeks to advance patient outcomes through science.